Company GSRX Industries Inc. Other OTC
Equities
GSRX
US36255V1070
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Retail
99.5
%
| 3 | 95.0 % | 11 | 99.5 % | +330.17% |
Wholesale
0.5
%
| 0 | 5.0 % | 0 | 0.5 % | -62.16% |
Sales per region
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 3 | 100.0 % | 11 | 100.0 % | +310.38% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 09/03/20 |
Director of Finance/CFO | 63 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 09/03/20 |
Jeff Rogers
BRD | Director/Board Member | 61 | 09/03/20 |
Shaun Dale
BRD | Director/Board Member | 47 | 22/04/20 |
Troy Dooly
BRD | Director/Board Member | 60 | 28/04/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 81,799,286 | 10,846,216 ( 13.26 %) | 0 | 13.26 % |
Stock B | 0 | 1,000 | 0 | 0 |
Company contact information
GSRX Industries, Inc.
5477 Nittany Valley Drive
17751, Mill Hall
+
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+37.78% | 723B | |
+31.21% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.53% | 244B | |
-4.54% | 208B | |
+10.02% | 210B | |
+9.32% | 169B |